|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Department of Pharmacology and Toxicology, School of Pharmacy, University of Regensburg, Regensburg, Germany
Fluorescence studies with purified human β2-adrenoceptor (β2AR) revealed that the endogenous catecholamines, (-)-epinephrine (EPI), (-)-norepinephrine (NE), and dopamine (DOP), stabilize distinct active receptor conformations. However, the functional relevance of these ligand-specific conformations is as yet poorly understood. We addressed this question by studying fusion proteins of the β1-adrenoceptor (β1AR) and β2AR with the short and long splice variants of Gs
(Gs
S and Gs
L), respectively. Fusion proteins ensure efficient receptor/G-protein coupling and defined stoichiometry of the coupling partners. EPI, NE, DOP, and the prototypical synthetic βAR agonist, (-)-isoproterenol (ISO), showed marked differences in their efficacies at stabilizing the high-affinity ternary complex at β1AR-Gs
and β2AR-Gs
fusion proteins. Ternary complex formation was more sensitive to disruption by GTP with the β2AR than with the β1AR. Generally, in steady-state GTPase assays, ISO, EPI, and NE were full agonists, and DOP was a partial agonist. Exceptionally, at β1AR-Gs
L, NE was only a partial agonist. Generally, in adenylyl cyclase assays, ISO, EPI, and NE were full agonists, and DOP was a partial agonist. At β2AR-Gs
L, NE was only a partial agonist. There was no correlation between efficacy at stabilizing the ternary complex and activating GTPase, and there were also dissociations between Ki values for high-affinity agonist binding and EC50 values for GTPase activation. In contrast to synthetic partial agonists, DOP did not exhibit increased efficacy at βAR-Gs
L versus βAR-Gs
S fusion proteins. In conclusion, our data with βAR-Gs
fusion proteins show that endogenous catecholamines and ISO stabilize distinct conformations in the β1AR and β2AR.
Address correspondence to: Dr. Roland Seifert, Institute of Pharmacology, Medical School of Hannover, Carl-Neuberg-str. 1, D-30625 Hannover, Germany. E-mail: Seifert.roland{at}mh-hannover.de
This article has been cited by other articles:
![]() |
M. Gottle, J. Geduhn, B. Konig, A. Gille, K. Hocherl, and R. Seifert Characterization of Mouse Heart Adenylyl Cyclase J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1156 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seifert and S. Dove Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities Mol. Pharmacol., January 1, 2009; 75(1): 13 - 18. [Abstract] [Full Text] [PDF] |
||||